The firm faces persistent liquidity pressure, highlighted by a negative OCF/NI ratio of -4.63 in 2025Q3 and continued share buybacks of $3.2 million despite significant operating cash burn.
| Cash from Operations | -110.22M | -208.81M | -64.52M | -2.6M | 1.34M | 650.13K |
| Operating CF Growth % | -2887.52% | -223.62% | -2379.48% | -293.8% | 106.54% | - |
| Operating CF / Revenue % | -56.08% | -186.56% | -97.17% | -5.82% | 5.94% | 53.09% |
| Net Income | 11.04M | -23.96M | 9.03M | -643.56K | 997.41K | 662.02K |
| Depreciation & Amortization | 17.08M | 7.91M | 3.41M | 4.28K | 31.24K | 0 |
| Stock-Based Compensation | 35.13M | 43.44M | 10.77M | 0 | 0 | 0 |
| Deferred Taxes | 6.63M | 6M | 466.58K | 889.94K | 0 | 0 |
| Other Non-Cash Items | -54.38M | -46.47M | -18.47M | 15.13M | 0 | 0 |
| Working Capital Changes | -125.75M | -195.73M | -69.73M | -17.98M | 314.1K | -11.88K |
| Cash from Investing | -17.77M | -4.96M | 2.24M | 246.5M | -241.53K | -1.25M |
| Capital Expenditures | -1.01M | -805.14K | -189.67K | -79.1K | -226.66K | 0 |
| Acquisitions | -564.15K | -2.43M | 0 | 0 | -14.86K | 16.4K |
| Purchase of Investments | -5.5M | -1.2M | -350K | -1.92M | -250K | -1.25M |
| Sale/Maturity of Investments | 0 | 0 | 0 | 1000K | 0 | 0 |
| Other Investing | -9.6M | -519.53K | 2.78M | 79.1K | 250K | -16.4K |
| Cash from Financing | 195M | 320.12M | 57.82M | -244.66M | -354.58K | 697.81K |
| Dividends Paid | 0 | 0 | 0 | -659.36K | -358.22K | -327.8K |
| Share Repurchases | -38.71M | -10.74M | -24.82M | -6.4M | 0 | 0 |
| Stock Issued | 89.7M | 181.7M | 972.26K | 0 | 0 | 0 |
| Debt Issuance (Net) | 1.24M | 1000K | 1000K | 1000K | 0 | 0 |
| Other Financing | -16.02M | -17.08M | -38.84M | -25.94M | 3.64K | 1.03M |
| Net Change in Cash | 67.01M | 106.36M | 25.5M | -766.56K | 746.66K | 97.95K |
| Exchange Rate Effect | 0 | 0 | 1000K | 0 | 0 | 0 |
| Cash at Beginning | 74.84M | 25.59M | 86.57K | 853.13K | 1.85M | 37.33K |
| Cash at End | 86.42M | 131.94M | 25.59M | 86.57K | 2.6M | 135.27K |
| Free Cash Flow | -111.15M | -209.62M | -64.71M | -2.68M | 1.12M | 650.13K |
| FCF Growth % | 14.97% | -223.92% | -2313.41% | -340.25% | 71.67% | - |
| FCF Margin % | -56.55% | -187.28% | -97.46% | -6% | 4.94% | 53.09% |
| FCF per Share | -1.15 | -2.96 | -1.12 | -0.09 | 0.03 | 0.02 |
Fair value accounting volatility
As reported in quarterly financial filings, Abacus Life consistently records negative operating cash flows, with a notable $32.8 million outflow in 2025Q3, suggesting that the cash required to maintain and acquire life settlement policies significantly exceeds the immediate cash inflows generated from the existing portfolio.
The persistent gap between net income and operating cash flow suggests that the company's profitability is heavily reliant on non-cash fair value adjustments rather than realized cash generation. Investors should monitor whether the ongoing cash burn is a temporary byproduct of aggressive portfolio scaling or a structural limitation of the current business model.
Based on the provided data, the OCF/NI ratio has exhibited extreme volatility, reaching a negative 4.63 in 2025Q3, which highlights a fundamental disconnect between reported accounting profits and the actual cash movement required to sustain the firm's operations and policy premium obligations.
This divergence appears to confirm that headline earnings are heavily influenced by unrealized gains that do not provide immediate liquidity. The reliance on non-cash accruals warrants further investigation into how the company intends to fund its long-term premium obligations if policy maturities do not accelerate in line with expectations.
According to recent financial statements, Abacus Life has continued to execute share buybacks, including $3.2 million in 2025Q3, despite recording significant negative operating cash flows, which may indicate a management priority on supporting equity valuation over preserving cash reserves for core policy acquisition activities.
The decision to return capital while the core business is cash-flow negative appears counterintuitive and may signal a desire to manage share count volatility. Investors should consider whether this capital allocation strategy is sustainable given the company's current reliance on external financing to fund its growth.
As indicated by the historical data, claims payments have trended upward from $973.4 thousand in 2023Q2 to $7.7 million in 2025Q3, reflecting the natural maturation of the life settlement portfolio and the increasing cash requirements associated with the firm's growing base of held policies.
While rising claims payments are a natural outcome of a growing portfolio, the timing of these outflows remains inherently unpredictable and sensitive to mortality trends. The firm's ability to manage these outflows against its premium payment obligations will be a critical determinant of its long-term liquidity profile.
Quick answers to the most common questions about buying ABLLL stock.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) generated $-208.8M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) reported negative free cash flow of $209.6M in 2024, indicating capital requirements exceeded cash from operations.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) spent $0.8M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2024, Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) spent $10.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.